- 1. MU
- [A country in the Middle East, bordering the Arabian Sea, Gulf of Oman, and Persian Gulf, between Yemen and the United Arab Emirates. (NCI) ( NCI )] (UMLS (NCI) C0028971) =Geographic Area
| - 51. MUCOPURUL CHR BRONCHITIS
- [ ] (UMLS (ICD9CM) C0155873) =Disease or Syndrome
|
- 2. Mu Heavy Chain Disease
- [A clonal disorder characterized by the secretion of a mu heavy chain that lacks a variable region. Most patients present with slowly progressive chronic lymphocytic leukemia (CLL). In contrast to most cases of CLL, Mu heavy chain disease is associated with hepatosplenomegaly and absence of lymphadenopathy. —2004 ( NCI )] (UMLS (NCI) C0242310) =Neoplastic Process ;
| - 52. Mucorales
- [An order of zygomycetous fungi, usually saprophytic, causing damage to food in storage, but which may cause respiratory infection or MUCORMYCOSIS in persons suffering from other debilitating diseases. ( MSH )] (UMLS (CSP) C0026717) =Fungus ;
|
- 3. mu receptor
- [A class of opioid receptors recognized by its pharmacological profile. Mu opioid receptors bind, in decreasing order of affinity, endorphins, dynorphins, met-enkephalin, and leu-enkephalin. They have also been shown to be molecular receptors for morphine. ( MSH )] (UMLS (CSP) C0066908) =Amino Acid, Peptide, or Protein; Receptor ;
| - 53. Mucosa
- (UMLS (HL7) C1561514) =Intellectual Product =Specimen Source Codes;
|
- 4. MUC-1 Antigen/SB AS-2
- (UMLS (NCI) C0935745) =Therapeutic or Preventive Procedure
| - 54. mucosa
- [mucus-secreting membrane lining all body cavities or passages that communicate with the exterior. ( CSP )] (UMLS (NCI) C0026724) =Tissue =Epithelial Tissue;
=gastric mucosa;
intestinal mucosa;
mouth mucosa;
|
- 5. MUC-1 KLH Vaccine
- [A peptide vaccine containing human tumor associated epithelial mucin (MUC1) conjugated with keyhole limpet hemocyanin (KLH), with potential antineoplastic activity. MUC1 antigen, a membrane bound glycoprotein expressed by most glandular and ductal epithelial cells, is overexpressed as an aberrant or deglycosylated form in various tumors such as breast, prostate and ovarian cancers. MUC1 antigen is conjugated with KLH, an immunostimulant and a hapten carrier, to enhance immune recognition. Vaccination with MUC1-KLH may result in the production of antibodies as well as elicit a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing the MUC1 antigen. ( NCI )] (UMLS (NCI) C0879579) MUC-1-KLH vaccine;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor | - 55. Mucosa of the Lower Lip
- [The lining of the inferior fleshy fold bordering the mouth. It is comprised of the epithelium, basement membrane, lamina propria mucosae, and lamina muscularis mucosae. ( NCI )] (UMLS (NCI) C0226939) =Body Part, Organ, or Organ Component
|
- 6. MUC-1 KLH Vaccine/QS21
- (UMLS (NCI) C0879580) =Therapeutic or Preventive Procedure
| - 56. Mucosa of the Upper Lip
- [The lining of the superior fleshy fold bordering the mouth. It is comprised of the epithelium, basement membrane, lamina propria mucosae, and lamina muscularis mucosae. ( NCI )] (UMLS (NCI) C0226933) =Body Part, Organ, or Organ Component
|
- 7. MUC-2-Globo H-KLH Conjugate Vaccine
- [A bivalent vaccine containing a glycosylated epitope of human mucin 2 (MUC2) and the Globo H hexasaccharide 1 (Globo H) antigen with potential antineoplastic activity. MUC2, a secretory or gel forming glycoprotein expressed predominantly in goblet cells of gastrointestinal and respiratory tracts, is overexpressed as an aberrant or deglycosylated form in various tumors such as gastric carcinomas and some hormone-refractory prostate cancers. Originally identified as a globo-series glycosphingolipid with an H-like determinant, Globo H is an epitope commonly found in glycolipids and glycoproteins, including mucins. This vaccine is conjugated with keyhole limpet hemocyanin (KLH), an immunostimulant and a hapten carrier, to enhance immune recognition and stability of the vaccine. Vaccination with this agent may elicit strong antibodies production as well as a cytotoxic T lymphocyte (CTL) response against tumor cells expressing MUC2 or Globo H. ( NCI )] (UMLS (NCI) C0935832) =Organic Chemical; Pharmacologic Substance; Immunologic Factor
| - 57. Mucosal absorption, intraduodenal
- [Mucosal absorption, intraduodenal ( HL7V3.0 )] (UMLS (HL7) C1555401) =Functional Concept =IntraduodenalRoute;
MucosalAbsorptionRoute |
- 8. MUC-2-Globo H-KLH Conjugate Vaccine/QS21
- (UMLS (NCI) C1134653) =Therapeutic or Preventive Procedure
| - 58. Mucosal absorption, intratracheal
- [Mucosal absorption, intratracheal ( HL7V3.0 )] (UMLS (HL7) C1555402) =Functional Concept =IntratrachealRoute;
MucosalAbsorptionRoute |
- 9. MUC-2-KLH
- [A peptide vaccine containing human mucin 2 (MUC2) protein conjugated with keyhole limpet hemocyanin (KLH), with potential antineoplastic activity. MUC2, a secretory or gel forming glycoprotein expressed predominantly in goblet cells of gastrointestinal and respiratory tracts, is overexpressed as an aberrant or deglycosylated form in various tumors such as gastric carcinomas and some hormone-refractory prostate cancers. MUC2 protein is conjugated with KLH, an immunostimulant and a hapten carrier, to enhance immune recognition. Vaccination with MUC2-KLH may result in the production of antibodies as well as elicit a cytotoxic T- lymphocyte (CTL) response against tumor cells expressing MUC2. ( NCI )] (UMLS (NCI) C0677979) =Organic Chemical; Pharmacologic Substance; Immunologic Factor
| - 59. Mucosal absorption, submucosal
- [Mucosal absorption, submucosal ( HL7V3.0 )] (UMLS (HL7) C1555400) =Functional Concept =SubmucosalRoute;
MucosalAbsorptionRoute |
- 10. MUC-2-KLH Vaccine/QS21
- (UMLS (NCI) C0879436) =Therapeutic or Preventive Procedure
| - 60. Mucosal cyst of postmastoidectomy cavity
- [ ] (UMLS (ICD9CM) C0155453) =Disease or Syndrome ;
|
- 11. MUC1
- [This gene plays a role in cellular signal transduction and is used as a biomarker for breast cancer. ( NCI )] (UMLS (NCI) C1417490) MUC1 Gene;
Mucin 1, Transmembrane Gene =Gene or Genome | - 61. Mucosal Immunity
- [immunity induced by the mucosal IgA response for specific resistance toward bacteria, viruses, and parasites infecting the respiratory, gastrointestinal, or genitourinary tracts. ( CSP )] (UMLS (NCI) C0282558) =Organ or Tissue Function ;
=secretory immune system;
|
- 12. Mucambo virus
- [ ] (UMLS (CSP) C0318740) =Virus
| - 62. Mucosal Lentiginous Malignant Melanoma
- [An acral lentiginous melanoma affecting mucosal surfaces. ( NCI )] (UMLS (NCI) C1266115) Mucosal Lentiginous Melanoma =Neoplastic Process
|
- 13. Mucicarmine stain
- [Stain, Mucicarmine ( HL7V3.0 )] (UMLS (HL7) C1293996) =Laboratory Procedure =ObservationMethod;
| - 63. MucosalAbsorptionRoute
- [Mucosal absorption ( HL7V3.0 )] (UMLS (HL7) C1701746) =Functional Concept =RouteByMethod;
=Mucosal absorption, submucosal;
Mucosal absorption, intraduodenal;
Mucosal absorption, intratracheal |
- 14. mucin
- [principal component of mucous. ( CSP )] (UMLS (CSP) C0026682) =Amino Acid, Peptide, or Protein; Biologically Active Substance =secretory protein;
| - 64. mucositis
- [A complication of some cancer therapies in which the lining of the digestive system becomes inflamed. Often seen as sores in the mouth. ( NCI )] (UMLS (NCI) C0333355) =Pathologic Function
|
- 15. Mucin-Producing Adenocarcinoma
- [An invasive adenocarcinoma composed of malignant glandular cells which produce mucin. ( NCI )] (UMLS (NCI) C0334368) =Neoplastic Process
| - 65. Mucositis (ulcerative) due to antineoplastic therapy
- [ ] (UMLS (ICD9CM) C1719526) MUCOSITS D/T ANTINEO RX;
=Disease or Syndrome |
- 16. Mucinol
- (UMLS (NCI) C1448435) =Organic Chemical; Pharmacologic Substance ;
| - 66. Mucositis (ulcerative) due to other drugs
- [ ] (UMLS (ICD9CM) C1719527) MUCOSITIS D/T DRUGS NEC;
=Disease or Syndrome |
- 17. Mucinous Adenocarcinoma of Ovary
- [Ovarian mucinous adenocarcinoma is a mucinous neoplasm characterized by cell atypia, increased layering of cells, greater complexity of glands and papillae (budding, bridging, appearance of solid foci) and areas of stromal invasion. —2002 ( NCI )] (UMLS (NCI) C1335167) Mucinous Adenocarcinoma of the Ovary;
Mucinous Carcinoma of Ovary;
Mucinous Carcinoma of the Ovary;
Ovarian Mucinous Adenocarcinoma;
Ovarian Mucinous Carcinoma =Neoplastic Process | - 67. Mucositis (ulcerative) of cervix, vagina, and vulva
- [ ] (UMLS (ICD9CM) C1719543) MUCOSITIS CERV,VAG,VULVA =Disease or Syndrome
|
- 18. Mucinous Adenocarcinoma of Stomach
- [A variant of gastric adenocarcinoma with more than half of the tumor containing extracellular mucinous pools. — 2003 ( NCI )] (UMLS (NCI) C1334809) Mucinous Adenocarcinoma of the Stomach;
Mucinous Gastric Adenocarcinoma;
Mucinous Stomach Adenocarcinoma;
=Neoplastic Process ;
| - 68. Mucosolvin
- (UMLS (NCI) C0699253) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
|
- 19. Mucinous Adenocarcinoma, Endocervical Type
- [A mucinous adenocarcinoma characterized by the presence of malignant glandular cells which resemble the endocervical epithelium. ( NCI )] (UMLS (NCI) C1266079) =Neoplastic Process
| - 69. mucous
- [A thick, slippery fluid produced by the membranes that line certain organs of the body, including the nose, mouth, throat, and vagina. ( NCI )] (UMLS (CSP) C0026727) =Body Substance =body fluid;
=bronchial mucous;
|
- 20. Mucinous Adenofibroma
- (UMLS (NCI) C0334499) =Neoplastic Process
| - 70. mucous colon
- [ ] (UMLS (CSP) C0598736) =Disease or Syndrome ;
|
- 21. Mucinous Bronchioloalveolar Carcinoma
- [A well differentiated morphologic variant of bronchiolo-alveolar lung carcinoma characterized by tall columnar cells and mucin production. ( NCI )] (UMLS (NCI) C1266035) Mucinous Bronchioloalveolar Lung Carcinoma;
Mucinous Bronchoalveolar Lung Carcinoma =Neoplastic Process | - 71. Mucous Connective Tissue
- [Loose connective tissue, the intercellular matrix of which consists predominantly of mucoid ground substance. Examples: Mucoid tissue of umbilical cord, mucoid tissue of vitreous body, mucoid tissue of nucleus pulposus. ( UWDA )] (UMLS (NCI) C0225345) =Tissue
|
- 22. Mucinous Cystadenocarcinoma of Ovary
- (UMLS (NCI) C0279665) =Neoplastic Process
| - 72. Mucous Membrane
- (UMLS (HL7) C1549524) =Functional Concept =drug administration route;
|
- 23. Mucinous Cystadenofibroma
- (UMLS (NCI) C1377844) =Neoplastic Process
| - 73. Mucous Membrane Hemangioma
- [A hemangioma arising from the mucous membranes. ( NCI )] (UMLS (NCI) C0240392) =Finding
|
- 24. Mucinous Cystic Neoplasm of Pancreas with Moderate Dysplasia
- [A low malignant potential cystic epithelial neoplasm arising from the exocrine pancreas. It occurs almost exclusively in women. Small tumors are usually found incidentally. Larger tumors usually produce symptoms related to compression of the adjacent structures. It is characterized by the presence of columnar, mucin-producing epithelial cells which form papillary projections or crypt-like invaginations. There is cellular pseudostratification and mitotic activity present. Complete surgical removal is usually associated with an excellent prognosis. ( NCI )] (UMLS (NCI) C1266077) Mucinous Cystic Neoplasm of the Pancreas with Moderate Dysplasia;
Mucinous Cystic Tumor of Pancreas with Moderate Dysplasia;
Mucinous Cystic Tumor of the Pancreas with Moderate Dysplasia;
Mucinous Cystic Tumor with Moderate Dysplasia;
Pancreatic Borderline Mucinous Cystic Neoplasm;
Pancreatic Low Grade Malignant Mucinous Cystic Neoplasm;
Pancreatic Mucinous Cystic Neoplasm with Moderate Dysplasia;
Pancreatic Mucinous Cystic Tumor with Moderate Dysplasia =Neoplastic Process | - 74. Mucous Membrane Leukoplakia
- (UMLS (NCI) C0240396) =Finding
|
- 25. Mucinous Degeneration
- (UMLS (NCI) C0333450) =Pathologic Function
| - 75. MUCOUS POLYP OF CERVIX
- (UMLS (ICD9CM) C0026725) =Neoplastic Process
|
- 26. Mucinous Lesion
- (UMLS (NCI) C1334810) =Finding ;
| - 76. Mucous Salivary Gland
- (UMLS (NCI) C0227440) =Body Part, Organ, or Organ Component
|
- 27. Mucinous Neoplasm
- (UMLS (NCI) C1334811) Mucinous Tumor =Neoplastic Process ;
| - 77. MucousMembraneRoute
- [Mucous membrane ( HL7V3.0 )] (UMLS (HL7) C1700803) =Functional Concept ;
=RouteBySite;
=Topical application, mucous membrane;
|
- 28. Mucinous Neoplasm of Ovary
- [Ovarian mucinous neoplasms are less common than the serous neoplasms and are bilateral in only 10% to 20% of the cases.As with their serous counterpart, they can be divided into benign (mucinous cystadenoma), borderline and malignant (mucinous adenocarcinoma and mucinous cystadenocarcinoma). Grossly, they tend to grow larger than the serous types and are partially or completely cystic, often multiloculated. A mucoid material is present in the lumen. —2002 ( NCI )] (UMLS (NCI) C1335168) Mucinous Neoplasm of the Ovary;
Mucinous Tumor of Ovary;
Mucinous Tumor of the Ovary;
Ovarian Mucinous Neoplasm;
Ovarian Mucinous Tumor =Neoplastic Process | - 78. Mucret
- (UMLS (NCI) C1510765) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
|
- 29. Muckleshoot Indian Tribe of the Muckleshoot Reserv
- (UMLS (HL7) C1554385) =Population Group =NativeEntityContiguous;
| - 79. Mucus
- (UMLS (HL7) C1546714) =Intellectual Product =Specimen Source Codes;
|
- 30. Mucocedyl
- (UMLS (NCI) C1510762) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 80. mudpuppy
- [A genus of the Proteidae family with five recognized species, which inhabit the Atlantic and Gulf drainages. ( MSH )] (UMLS (CSP) C0027548) =Amphibian ;
|
- 31. Mucocele of salivary gland
- [A form of retention cyst of the floor of the mouth, usually due to obstruction of the ducts of the submaxillary or sublingual glands, presenting a slowly enlarging painless deep burrowing mucocele of one side of the mouth. It is also called sublingual cyst and sublingual ptyalocele. ( MSH )] (UMLS (ICD9CM) C0026686) =Disease or Syndrome; Anatomical Abnormality =cyst;
Mouth Diseases | - 81. MUGA
- [A multi-gated acquisition (MUGA) scan and a form of radionuclide imaging that provides a comprehensive look at blood flow and the function of the lower chambers of the heart ventricles. ( NCI )] (UMLS (NCI) C0521317) =Diagnostic Procedure
|
- 32. Mucocutaneous Candidiasis
- (UMLS (NCI) C0006848) =Disease or Syndrome
| - 82. MUL GEST-FET REDUCT ANTE
- [ ] (UMLS (ICD9CM) C1561649) Multiple gestation following (elective) fetal reduction, antepartum condition or complication;
=Finding |
- 33. Mucoepidermoid Breast Carcinoma
- [A carcinoma of the breast characterized by pools of mucin and islands of malignant squamous cells. Mucoepidermoid carcinomas of the breast are extremely rare. —2003 ( NCI )] (UMLS (NCI) C1334813) Mucoepidermoid Carcinoma of Breast;
Mucoepidermoid Carcinoma of the Breast;
=Neoplastic Process ;
| - 83. MUL GEST-FET REDUCT UNSP
- [ ] (UMLS (ICD9CM) C1561647) Multiple gestation following (elective) fetal reduction, unspecified as to episode of care or not applicable;
=Finding |
- 34. Mucoepidermoid Carcinoma of Oral Cavity
- (UMLS (NCI) C0280309) =Neoplastic Process
| - 84. MuLCMS (micro liquid chromatography tandem mass spectrometry
- [ ] (UMLS (CSP) C1328930) =Laboratory Procedure; ;
|
- 35. Mucoepidermoid Carcinoma of Parotid
- (UMLS (NCI) C1335363) Mucoepidermoid Carcinoma of Parotid Gland;
Mucoepidermoid Carcinoma of the Parotid;
Mucoepidermoid Carcinoma of the Parotid Gland;
Parotid Gland Mucoepidermoid Carcinoma;
Parotid Mucoepidermoid Carcinoma =Neoplastic Process ;
| - 85. Muller's cell
- [elongated neuroglial cells extending across the thickness of the retina; serves for structural as well as nutritional support system of the retina and is similar to the astrocytes of CNS. ( CSP )] (UMLS (CSP) C0596979) =Cell =glia;
Eye - Retina (MMHCC) |
- 36. Mucoepidermoid Carcinoma of Salivary Gland
- (UMLS (NCI) C1335903) Mucoepidermoid Carcinoma of the Salivary Gland;
Salivary Gland Mucoepidermoid Carcinoma;
=Neoplastic Process ;
| - 86. Mullerian Duct
- [A pair of ducts near the WOLFFIAN DUCTS in a developing embryo. In the male embryo, they degenerate with the appearance of testicular ANTI-MULLERIAN HORMONE. In the absence of anti-mullerian hormone, mullerian ducts give rise to the female reproductive tract, including the OVIDUCTS; UTERUS; CERVIX; and VAGINA. ( MSH )] (UMLS (NCI) C0026732) =Embryonic Structure
|
- 37. Mucoepidermoid Carcinoma of Skin
- (UMLS (NCI) C0346019) =Neoplastic Process
| - 87. MULT ANOM ANTER SEG-EYE
- [ ] (UMLS (ICD9CM) C0158562) =Congenital Abnormality ;
|
- 38. Mucoepidermoid Carcinoma of Submandibular Gland
- (UMLS (NCI) C1336524) Mucoepidermoid Carcinoma of the Submandibular Gland;
Submandibular Gland Mucoepidermoid Carcinoma;
=Neoplastic Process ;
| - 88. MULT BIRTH NOS-HOSP W CS
- [ ] (UMLS (ICD9CM) C0260644) =Finding
|
- 39. Mucoepidermoid Carcinoma of the Thymus
- [A rare primary thymic carcinoma, characterized by the presence of squamous cells, intermediate type cells, and mucus-producing cells. Published information on clinical course is limited to single-case reports. — 2005 ( NCI )] (UMLS (NCI) C1334814) Mucoepidermoid Carcinoma of Thymus;
Thymic Mucoepidermoid Carcinoma;
Thymus Mucoepidermoid Carcinoma =Neoplastic Process ;
| - 89. MULT BIRTH NOS-NONHOSP
- [ ] (UMLS (ICD9CM) C0260646) =Finding
|
- 40. mucoid
- [ ] (UMLS (CSP) C0205295) =Qualitative Concept
| - 90. MULT BRTH NOS-BEFORE ADM
- [ ] (UMLS (ICD9CM) C0260645) =Finding
|
- 41. mucoid exopolysaccharide Pseudomonas aeruginosa
- [ ] (UMLS (CSP) C0599235) =Carbohydrate; Immunologic Factor
| - 91. MULT BRTH NOS-HOS W/O CS
- [ ] (UMLS (ICD9CM) C0260643) =Finding
|
- 42. Mucoid Stroma Formation
- (UMLS (NCI) C1334812) =Finding ;
| - 92. MULT CONGEN ANOMAL NEC
- (UMLS (ICD9CM) C0026758) =Congenital Abnormality
|
- 43. Mucolator
- (UMLS (NCI) C1510763) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 93. MULT CRANIAL NERVE PALSY
- [ ] (UMLS (ICD9CM) C0154733) =Disease or Syndrome
|
- 44. mucolipidosis I
- [ ] (UMLS (CSP) C0268226) =Disease or Syndrome ;
| - 94. MULT DEFECTS OF RETINA
- [ ] (UMLS (ICD9CM) C0154827) =Acquired Abnormality; Disease or Syndrome
|
- 45. Mucolyticum
- (UMLS (NCI) C1510764) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 95. MULT ENDO NEOP TYPE IIB
- [ ] (UMLS (ICD9CM) C1955744) Multiple endocrine neoplasia [MEN] type IIB;
=Neoplastic Process |
- 46. Mucomyst
- (UMLS (NCI) C0699252) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| - 96. MULT EPIPHYSEAL DYSPLAS
- (UMLS (ICD9CM) C0026760) =Congenital Abnormality; Disease or Syndrome ;
|
- 47. mucopeptide
- [ ] (UMLS (CSP) C0599104) =Amino Acid, Peptide, or Protein
| - 97. MULT FX MANDIBLE-OPEN
- [ ] (UMLS (ICD9CM) C0159344) =Injury or Poisoning
|
- 48. mucopolysaccharidosis type VII
- [Mucopolysaccharidosis characterized by excessive dermatan and heparan sulfates in the urine and Hurler-like features. It is caused by a deficiency of beta-glucuronidase. ( MSH )] (UMLS (CSP) C0085132) =Disease or Syndrome ;
=Mucopolysaccharidoses;
| - 98. MULT FX METACARPUS-OPEN
- [ ] (UMLS (ICD9CM) C0435656) =Injury or Poisoning
|
- 49. mucoprotein
- [Conjugated proteins in which mucopolysaccharides are combined with proteins. The mucopolysaccharide moiety is the predominant group with the protein making up only a small percentage of the total weight. ( MSH )] (UMLS (CSP) C0026714) =Amino Acid, Peptide, or Protein; Carbohydrate; Biologically Active Substance ;
=glycoprotein;
=intrinsic factor;
| - 99. MULT GES MALPRES-ANTEPAR
- [ ] (UMLS (ICD9CM) C0156951) =Disease or Syndrome
|
- 50. MUCOPUR CONJUNCTIVIT NEC
- [ ] (UMLS (ICD9CM) C0029668) =Disease or Syndrome
| - 100. MULT GES W FET LOSS-ANTE
- [ ] (UMLS (ICD9CM) C0156916) =Disease or Syndrome
|
home
